PharmiWeb.com - Global Pharma News & Resources
21-Jun-2019

Preterm Birth and PROM Testing Market Size is Projected to Jump USD 1.31 Billion by 2026

Global Preterm Birth and PROM Testing Market Size is expected to reach USD 1.31 Billion by 2026 and growing CAGR around 1.74 % during the forecast period.

Premature rupture of membranes (PROM) causes roughly 4.5 Million preterm births every year, around the world. Comprehensively, premature birth is among the most incessant reasons for death among neonates within the first month of their life. The endorsement of preterm birth and PROM testing demonstrative units has presented an exceptionally effectual yet cost-effective choice for testing premature rupture of membranes in symptomatic patients. These tests are progressively supplanting conventional standard-of-care tests (Fern and Nitrazine) propelled by their usability and high affectability.

Rising occurrence of preterm births, expanding land reach by market players, extreme interest for the viable conclusion of preterm births, and propelled sedate conveyance gadgets are expected to drive the market. The increment in the number of preterm births, high frequency of preterm births, ascend in the quantity of claim to fame facilities, and simple location of preterm birth through PROM tests are projected to enlarge the fragment. The preterm birth tests segment capture the highest revenue share of the worldwide preterm birth and PROM testing market. However, the accessibility of different tests in the market is estimated to hamper the market growth over the forecast period.

Free Download Sample Report Pages for Better Understanding@ https://www.acumenresearchandconsulting.com/request-sample/1263

The global preterm birth and PROM testing market is divided into test type, end-user, and region. On the basis of test type segment, the worldwide preterm birth and PROM testing market is divided into preterm birth tests and PROM tests. Whereas, preterm birth tests segment includes pelvic exam, ultrasound, uterine monitoring, and biomarkers, and prom test includes nitrazine test, ferning test, pooling, ultrasound, fetal fibronectin test, biomarker tests, and others. On the basis of application, the worldwide preterm birth and PROM testing market is segmented into hospitals, diagnostic laboratories, and others. Based on the region, the worldwide preterm birth and PROM testing market is divided into North America, Latin America, Europe, Middle East and Africa, and the Asia Pacific.

Preterm birth is a birth that happens before 37weeks of pregnancy is finished. Premature rupture of membranes (PROM) is a typical pregnancy complexity and is one of the main sources of preterm births. Preterm birth and premature rupture of membranes (PROM) testing are comprehensively sectioned into preterm birth testing and premature rupture of membrane (PROM) testing. The preterm birth testing incorporates fetal fibronectin (fFN) test, Kleihauer blood test, total blood tally test, and c-responsive protein test; while PROM testing incorporates nitrazine tests, ferning test, biomarker tests, such as, Placental Alpha Microglobulin-1 (PAMG-1) Test, IGFBP-1 (Insulin-Like Growth Factor Binding Protein-1) Test, and Alpha-Fetoprotein (AFP) Test.

As per WHO, preterm birth is a worldwide medical problem with about 1.5 million preterm births every year. Moreover, about 60% of preterm births happen in South Asia and sub-Saharan African nations. In this manner, these untapped developing markets are projected to offer potential development opportunities to players working in the market during the estimated time frame. Nonetheless, low dependability of test outcomes is probably posing a challenge, hindering the market growth.

To Purchase this Premium Report at https://www.acumenresearchandconsulting.com/buy-now/0/1263

The high presence of major players, incremented demand for preterm birth testing, and an increase in preterm birth rates are some factors boosting the market growth in North America. Innovative and technical advancement, a rise in the number of endorsements for preterm and PROM tests from the European Commission, and rising demand after for preterm birth symptomatic tests fueling the preterm birth and PROM testing market in Europe. Concentrate on early medical issues in females, a rise in government activities related to maternal wellbeing, and increment in the number of preterm births are some of the factors that are driving the market in the Asia Pacific. The growing market in Latin America owing to a quick selection of new advancements, increasing use of point-of-care testing gadgets and devices, and the increase in the volume of players offering the target product in the market. Furthermore, the rise in awareness related to item offerings for preterm birth and PROM testing is expected to expand the market in Latin America during the estimated time frame.

Major companies contributing the global preterm birth and PROM testing market are Qiagen, Hologic, Cooper Surgical, Abbott Laboratories, Medixbiochemica, Sera Prognostics, Biosynex, and IQ Products.

TABLE OF CONTENT

CHAPTER 1. INDUSTRY OVERVIEW

1.1. Definition and Scope
1.1.1. Definition of Preterm Birth and PROM Testing
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Preterm Birth and PROM Testing Market By Test Type
1.2.2.1. Global Preterm Birth and PROM Testing Market Revenue and Growth Rate Comparison By Test Type (2015-2026)
1.2.2.2. Global Preterm Birth and PROM Testing Market Revenue Share By Test Type in 2017
1.2.2.3. Preterm Birth Tests
1.2.2.3.1. Pelvic Exam
1.2.2.3.2. Ultrasound
1.2.2.3.3. Uterine Monitoring
1.2.2.3.4. Biomarkers
1.2.2.4. PROM Tests
1.2.2.4.1. Nitrazine Test
1.2.2.4.2. Ferning Test
1.2.2.4.3. Pooling
1.2.2.4.4. Ultrasound
1.2.2.4.5. Fetal Fibronectin Test
1.2.2.4.6. Biomarker Tests
1.2.2.4.7. Others
1.2.2.4.8. Market Segmentation, By End-user:
1.2.2.4.9. Hospitals
1.2.2.4.10. Diagnostic Laboratories
1.2.2.5. Others
1.2.3. Preterm Birth and PROM Testing Market by Geography
1.2.3.1. Global Preterm Birth and PROM Testing Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.3.2. North America Preterm Birth and PROM Testing Market Revenue and Growth Rate (2015-2026)
1.2.3.3. Europe Preterm Birth and PROM Testing Market Revenue and Growth Rate (2015-2026)
1.2.3.4. Asia-Pacific Preterm Birth and PROM Testing Market Revenue and Growth Rate (2015-2026)
1.2.3.5. Latin America Preterm Birth and PROM Testing Market Revenue and Growth Rate (2015-2026)
1.2.3.6. Middle East and Africa (MEA) Preterm Birth and PROM Testing Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS

2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porterrsquo;s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS

3.1. Capacity and Commercial Production Date of Global Preterm Birth and PROM Testing Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Preterm Birth and PROM Testing Major Manufacturers in 2017
3.3. Ramp;D Status and Technology Source of Global Preterm Birth and PROM Testing Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Preterm Birth and PROM Testing Major Manufacturers in 2017

CHAPTER 4. PRETERM BIRTH AND PROM TESTING MARKET BY TEST TYPE

4.1. Global Preterm Birth and PROM Testing Revenue By Test Type
4.2. Preterm Birth Tests
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.2.3. Pelvic Exam
4.2.4. Ultrasound
4.2.5. Uterine Monitoring
4.2.6. Biomarkers
4.3. PROM Tests
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3.3. Nitrazine Test
4.3.4. Ferning Test
4.3.5. Pooling
4.3.6. Ultrasound
4.3.7. Fetal Fibronectin Test
4.3.8. Biomarker Tests
4.3.9. Others
4.3.10. Market Segmentation, By End-user:
4.3.11. Hospitals
4.3.12. Diagnostic Laboratories
4.4. Others
4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. NORTH AMERICA PRETERM BIRTH AND PROM TESTING MARKET BY COUNTRY

5.1. North America Preterm Birth and PROM Testing Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2. North America Preterm Birth and PROM Testing Market Revenue Share Comparison, 2015 amp; 2026 (%)
5.3. U.S.
5.3.1. U.S. Preterm Birth and PROM Testing Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
5.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
5.4. Canada
5.4.1. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
5.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
5.5. Mexico
5.5.1. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
5.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 6. EUROPE PRETERM BIRTH AND PROM TESTING MARKET BY COUNTRY

6.1. Europe Preterm Birth and PROM Testing Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2. Europe Preterm Birth and PROM Testing Market Revenue Share Comparison, 2015 amp; 2026 (%)
6.3. UK
6.3.1. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
6.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
6.4. Germany
6.4.1. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
6.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
6.5. France
6.5.1. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
6.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
6.6. Spain
6.6.1. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
6.6.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
6.7. Rest of Europe
6.7.1. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
6.7.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 7. ASIA-PACIFIC PRETERM BIRTH AND PROM TESTING MARKET BY COUNTRY

7.1. Asia-Pacific Preterm Birth and PROM Testing Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. Asia-Pacific Preterm Birth and PROM Testing Market Revenue Share Comparison, 2015 amp; 2026 (%)
7.3. China
7.3.1. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
7.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.4. Japan
7.4.1. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
7.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.5. India
7.5.1. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
7.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.6. Australia
7.6.1. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
7.6.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.7. South Korea
7.7.1. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
7.7.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.8. Rest of Asia-Pacific
7.8.1. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
7.8.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 8. LATIN AMERICA PRETERM BIRTH AND PROM TESTING MARKET BY COUNTRY

8.1. Latin America Preterm Birth and PROM Testing Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Latin America Preterm Birth and PROM Testing Market Revenue Share Comparison, 2015 amp; 2026 (%)
8.3. Brazil
8.3.1. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
8.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.4. Argentina
8.4.1. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
8.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.5. Rest of Latin America
8.5.1. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
8.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 9. MIDDLE EAST PRETERM BIRTH AND PROM TESTING MARKET BY COUNTRY

9.1. Middle East Preterm Birth and PROM Testing Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Middle East Preterm Birth and PROM Testing Market Revenue Share Comparison, 2015 amp; 2026 (%)
9.3. Saudi Arabia
9.3.1. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
9.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.4. UAE
9.4.1. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
9.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.5. Rest of Middle East
9.5.1. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
9.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 10. AFRICA PRETERM BIRTH AND PROM TESTING MARKET BY COUNTRY

10.1. Africa Preterm Birth and PROM Testing Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Africa Preterm Birth and PROM Testing Market Revenue Share Comparison, 2015 amp; 2026 (%)
10.3. South Africa
10.3.1. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
10.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.4. Egypt
10.4.1. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
10.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.5. Rest of Africa
10.5.1. Market Revenue and Forecast By Test Type, 2015 - 2026 ($Million)
10.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 11. COMPANY PROFILE

11.1. Qiagen
11.1.1. Company Snapshot
11.1.2. Overview
11.1.3. Financial Overview
11.1.4. Product Portfolio
11.1.5. Key Developments
11.1.6. Strategies
11.2. Hologic
11.2.1. Company Snapshot
11.2.2. Overview
11.2.3. Financial Overview
11.2.4. Product Portfolio
11.2.5. Key Developments
11.2.6. Strategies
11.3. Cooper Surgical
11.3.1. Company Snapshot
11.3.2. Overview
11.3.3. Financial Overview
11.3.4. Product Portfolio
11.3.5. Key Developments
11.3.6. Strategies
11.4. Abbott Laboratories
11.4.1. Company Snapshot
11.4.2. Overview
11.4.3. Financial Overview
11.4.4. Product Portfolio
11.4.5. Key Developments
11.4.6. Strategies
11.5. Medixbiochemica
11.5.1. Company Snapshot
11.5.2. Overview
11.5.3. Financial Overview
11.5.4. Product Portfolio
11.5.5. Key Developments
11.5.6. Strategies
11.6. Sera Prognostics
11.6.1. Company Snapshot
11.6.2. Overview
11.6.3. Financial Overview
11.6.4. Product Portfolio
11.6.5. Key Developments
11.6.6. Strategies
11.7. Biosynex
11.7.1. Company Snapshot
11.7.2. Overview
11.7.3. Financial Overview
11.7.4. Product Portfolio
11.7.5. Key Developments
11.7.6. Strategies
11.8. IQ Products
11.8.1. Company Snapshot
11.8.2. Overview
11.8.3. Financial Overview
11.8.4. Product Portfolio
11.8.5. Key Developments
11.8.6. Strategies
11.9. Others
11.9.1. Company Snapshot
11.9.2. Overview
11.9.3. Financial Overview
11.9.4. Product Portfolio
11.9.5. Key Developments
11.9.6. Strategies

CHAPTER 12. RESEARCH APPROACH

12.1. Research Methodology
12.1.1. Initial Data Search
12.1.2. Secondary Research
12.1.3. Primary Research
12.2. Assumptions and Scope

Buy this Premium Research Report at https://www.acumenresearchandconsulting.com/buy-now/0/1263

The report is readily available and can be dispatched immediately after payment confirmation.

Would like to place an order or any question, please feel free to contact atsales@acumenresearchandconsulting.com| +1 407 915 4157

About Acumen Research and Consulting:

Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to makefact baseddecisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.

Editor Details

Last Updated: 21-Jun-2019